Novartis headquarters opens in White City, London12 February 2020 | By Victoria Rees (European Pharmaceutical Review)In a formal ceremony, the new headquarters for Novartis has been opened in White City, London, in close proximity to Imperial College London’s research campus.
Solanezumab fails to meet primary endpoint of Phase II/III Alzheimer’s trial12 February 2020 | By Hannah Balfour (European Pharmaceutical Review)The developers have announced solanezumab failed to show disease-modifying properties against dominantly inherited Alzheimer's disease (DIAD).
The FDA and FTC team up to prevent anti-competitive practices12 February 2020 | By Hannah Balfour (European Pharmaceutical Review)The two agencies have signed a statement of their intent to combat anti-competitive practices which are preventing the adoption of biosimilars in the US drug market.
Pharma industry calls for GMP agreement between EU and UK11 February 2020 | By Rachael Harper (European Pharmaceutical Review)EFPIA, Medicines for Europe and AESGP have called for a Mutual Recognition Agreement on good manufacturing practice in regards to the future relationship between the UK and the EU.
BTK inhibitor meets primary endpoint in Phase IIb trial treating MS11 February 2020 | By Hannah Balfour (European Pharmaceutical Review)According to its developers, SAR442168 significantly reduced the appearance of new gadolinium (Gd)-enhancing T1-hyperintense brain lesions in the 120 trial patients.
Anti-counterfeit drugs packaging market growing at 13.2 percent CAGR11 February 2020 | By Hannah Balfour (European Pharmaceutical Review)Research has found that technological innovation and legislation are to drive the growth of the global anti-counterfeit packaging market.
Industry executives call for track and trace systems in south-east Asia11 February 2020 | By Victoria Rees (European Pharmaceutical Review)A report has outlined the opportunities and challenges for the pharmaceutical industry in south-east Asia, including implementing a track and trace system as well as generics potential.
Biologics patent expiry to positively impact US pharma, says report11 February 2020 | By Victoria Rees (European Pharmaceutical Review)New research has suggested that the expiration of biologics patents will be the factor that positively impacts US pharma the most this year.
Safe’n’Spray™, the smart electronic concept device with child-resistant and locking features, wins the ‘Best Innovation In Drug Delivery Device’ Award at Pharmapack 202011 February 2020 | By NemeraA team of industry experts awarded Nemera’s Safe’n’Spray with a prestigious Pharmapack Award for ‘Best Innovation in Drug Delivery Device’.
Multiple myeloma treatment receives IND from FDA10 February 2020 | By Victoria Rees (European Pharmaceutical Review)The FDA has granted Investigational New Drug (IND) authorisation to KP1237 for the treatment of multiple myeloma using a patient's own Natural Killer cells.
MAP hydrogel biodegradation enhances stem cell growth10 February 2020 | By Hannah Balfour (European Pharmaceutical Review)A study showed that bone stem cells rearrange degrading microporous annealed particle (MAP) hydrogels, promoting their growth.
Glenmark recalls iohexol solution batches as precautionary measure10 February 2020 | By Victoria Rees (European Pharmaceutical Review)Out of specification results from stability studies have led Glenmark Pharmaceuticals to recall batches of their iohexol solution for injection in the UK.
Johnson & Johnson “most valuable” pharma brand, says report10 February 2020 | By Victoria Rees (European Pharmaceutical Review)A new report has revealed Johnson & Johnson as the most valuable pharmaceutical brand, despite a decrease in profits from last year.
4D-printed microneedles for drug delivery and biosensing7 February 2020 | By Hannah Balfour (European Pharmaceutical Review)Researchers using 4D printing have developed microneedles with backwards-facing barbs that they suggest could replace hypodermic needles in prolonged drug delivery or biosensing in future.
Pharmapack Europe 2020 award winners announced7 February 2020 | By Victoria Rees (European Pharmaceutical Review)The winners from the 2020 Pharmapack Awards have been announced, with eight awards granted across two categories in the pharmaceutical packaging and drug delivery industries.
